# Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive

> **NCT05905354** · NA · UNKNOWN · sponsor: **Newish Technology (Beijing) Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- HSIL of Cervix

## Interventions

- **BIOLOGICAL:** NWRD08

## Key facts

- **NCT ID:** NCT05905354
- **Lead sponsor:** Newish Technology (Beijing) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-07
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05905354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05905354, "Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05905354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*